Drug Approval | August 25, 2024
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
A committee to be formed to suggest measures for ensuring the safety of healthcare professionals
The emergence of new infections in India is a growing concern
Majority of organizations are looking to increase investments in public and hybrid cloud
The partnership marks a significant milestone in integrating digital health education into medical curricula
Subscribe To Our Newsletter & Stay Updated
